Safety Evaluation of Neo Transgenic Pigs by Studying Changes in Gut Microbiota Using High-Throughput Sequencing Technology
Autor: | Maoxue Tang, Qingqing Wang, Pengfei Gao, Shengwang Jiang, Jie Liu, Dezun Ma, Ke Jiang, Wentao Cui, Jian Hou, Chunbo Cai, Hegang Li, Lili Qian |
---|---|
Rok vydání: | 2015 |
Předmět: |
0301 basic medicine
Swine Kanamycin kinase Agricultural Biotechnology lcsh:Medicine Artificial Gene Amplification and Extension Gut flora medicine.disease_cause Polymerase Chain Reaction Animals Genetically Modified Feces Antibiotics Lactobacillus Medicine and Health Sciences Transgenes lcsh:Science Mammals Multidisciplinary biology Antimicrobials Genetically Modified Organisms High-Throughput Nucleotide Sequencing Drugs Agriculture Neomycins Neomycin Transgenic Engineering Vertebrates Anatomy Genetic Engineering medicine.drug Research Article Biotechnology Livestock Gene Transfer Horizontal Firmicutes Transgene 030106 microbiology Research and Analysis Methods Microbiology 03 medical and health sciences Ileum Microbial Control Drug Resistance Bacterial Proteobacteria medicine Escherichia coli Animals Molecular Biology Techniques Molecular Biology Pharmacology Kanamycin Kinase Genetically Modified Animals Bacteria Bacteroidetes lcsh:R Gut Bacteria Organisms Biology and Life Sciences biology.organism_classification Gastrointestinal Microbiome Gastrointestinal Tract 030104 developmental biology lcsh:Q Hafnia Shigella Digestive System |
Zdroj: | PLoS ONE PLoS ONE, Vol 11, Iss 3, p e0150937 (2016) |
ISSN: | 1932-6203 |
Popis: | The neo (neomycin phosphotransferase) gene is widely used as a selection marker in the production of genetically engineered animals and plants. Recent attention has been focused on safety concerns regarding neo transgene expression. In this study, neo transgenic and non-transgenic piglets were randomly assigned into Group A and Group B to evaluate effects of neo transgene by studying changes in gut microbiota using high-throughput sequencing. Group A pigs were fed a standard diet supplemented with antibiotic neomycin; Group B pigs were fed a standard diet. We examined horizontal transfer of exogenous neo gene using multiplex PCR; and investigated if the presence of secreted NPT II (neo expression product) in the intestine could lead to some protection against neomycin in transgenic pigs by monitoring different patterns of changes in gut microbiota in Group A animals. The unintended effects of neo transgene on gut microbiota were studied in Group B animals. Horizontal gene transfer was not detected in gut microbiota of any transgenic pigs. In Group A, a significant difference was observed between transgenic pigs and non-transgenic pigs in pattern of changes in Proteobacteria populations in fecal samples during and post neomycin feeding. In Group B, there were significant differences in the relative abundance of phyla Firmicutes, Bacteroidetes and Proteobacteria, and genera Lactobacillus and Escherichia-Shigella-Hafnia between transgenic pigs and non-transgenic pigs. We speculate that the secretion of NPT II from transgenic tissues/cells into gut microbiota results in the inhibition of neomycin activity and the different patterns of changes in bacterial populations. Furthermore, the neo gene also leads to unintended effects on gut microbiota in transgenic pigs that were fed with basic diet (not supplemented with neomycin). Thus, our data in this study caution that wide use of the neo transgene in genetically engineered animals should be carefully considered and fully assessed. |
Databáze: | OpenAIRE |
Externí odkaz: |